Try our Advanced Search for more refined results

AOP Orphan Pharmaceuticals AG v. Pharmaessentia Corporation

  1. March 11, 2022

    AOP Orphan Wants Remnants Of €142M Award OK'd In Mass.

    Although a German court ruled to set aside a €142 million ($161.8 million) arbitral award issued to Austrian pharmaceutical company AOP Orphan last month, the Austrian company and the Taiwanese drug developer who would have had to pay it have differing opinions on where their Massachusetts federal court dispute should go from here.

  2. February 16, 2022

    Austrian Pharma Co.'s €142M Award Nixed In Germany

    A German court has set aside a €142 million ($161.8 million) damages award issued to Austrian pharmaceutical company AOP Orphan in the midst of a contentious dispute with Taiwanese drug developer PharmaEssentia Corp. over an ill-fated deal to develop a new blood cancer treatment.

  3. February 11, 2022

    Taiwanese Pharma Co. Says €142M Award Can't Be Enforced

    Taiwanese drug developer PharmaEssentia Corp. is fighting the enforcement of a €142 million ($161.1 million) arbitral award issued to Austrian pharmaceutical company AOP Orphan following an ill-fated deal to develop a new blood cancer treatment, arguing that it was denied due process in the arbitration.

  4. January 31, 2022

    Taiwanese Pharma Co. Beats Sanctions In AOP Arb. Fight

    Taiwanese pharmaceutical company PharmaEssentia avoided sanctions and a default judgment on Friday when a Massachusetts federal judge ruled that a previous order for the firm to pay attorneys fees for Austrian pharmaceutical company AOP Orphan during their fight over a €142 million arbitral award had already addressed PharmaEssentia's withholding of discovery.

  5. November 02, 2021

    Taiwanese Pharma Co. Can't Shake AOP Sanction Bid

    Taiwanese pharmaceutical company PharmaEssentia can't escape sanctions in Massachusetts federal court for being tight-lipped during discovery in a feud with Austrian pharmaceutical company AOP Orphan over a €142 million arbitral award, a judge ruled Monday.

  6. October 22, 2021

    Pharma Co. Wants €140M AOP Orphan Award Suit Tossed

    Taiwanese pharmaceutical company PharmaEssentia renewed its bid to toss litigation over a disputed €142 million ($165 million) arbitral award secured by Austrian pharmaceutical company AOP Orphan, saying a Massachusetts federal court lacks jurisdiction over the suit because the company has insufficient ties to the state.

  7. October 19, 2021

    Taiwanese Pharma Co. Fights AOP Orphan's Sanctions Bid

    Taiwanese pharmaceutical company PharmaEssentia has told a Massachusetts federal judge that despite its immense cooperation with discovery requests, Austrian pharmaceutical company AOP Orphan has "aggressively" sought sanctions for a single document request in litigation over an arbitral award exceeding €142 million.

  8. October 05, 2021

    AOP Orphan Seeks Sanctions On Taiwanese Pharma Co.

    Austrian pharmaceutical company AOP Orphan is seeking sanctions against Taiwanese pharmaceutical company PharmaEssentia, saying the latter has so far ducked the former's efforts to establish jurisdiction in litigation to enforce a more than €142 million arbitral award that arose from a soured licensing deal.

  9. June 21, 2021

    Pharma Co. Can't Shake €140M AOP Orphan Award Yet

    A Massachusetts federal judge rejected for now an attempt by Taiwanese pharmaceutical company PharmaEssentia to toss a €140M arbitral award won by Austrian pharmaceutical company AOP Orphan, which the judge said presented a "colorable claim that jurisdiction exists."

  10. May 05, 2021

    Pharma Co. Says €140M Award Suit Doesn't Belong In Mass.

    Taiwanese pharmaceutical company PharmaEssentia urged a Massachusetts federal judge to toss Austrian pharmaceutical company AOP Orphan's €140 million ($169.7 million) award confirmation suit, arguing that the court does not have general or specific jurisdiction over this case.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!